71
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocages

, , , , , , , , , & show all
Pages 4353-4362 | Published online: 09 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Riki Toita, Masaharu Murata, Kana Abe, Sayoko Narahara, Jing Shu Piao, Jeong-Hun Kang, Kenoki Ohuchida & Makoto Hashizume. (2013) Biological evaluation of protein nanocapsules containing doxorubicin. International Journal of Nanomedicine 8, pages 1989-1999.
Read now

Articles from other publishers (22)

Alaa A.A. Aljabali, Meriem Rezigue, Rawan H. Alsharedeh, Mohammad A. Obeid, Vijay Mishra, Ángel Serrano-Aroca & Murtaza M. Tambuwala. (2022) Protein-Based Drug Delivery Nanomedicine Platforms: Recent Developments. Pharmaceutical Nanotechnology 10:4, pages 257-267.
Crossref
Huizhen Sun, Le Chang, Ying Yan & Lunan Wang. (2020) Hepatitis B virus pre‐S region: Clinical implications and applications. Reviews in Medical Virology 31:4.
Crossref
Maribel Cayetano-Cruz, Josefina Valadez-García, Carmen Méndez & Ismael Bustos-Jaimes. (2019) Virus-like Nanoparticles Derived from Parvovirus B19 Efficiently Internalize in Human Heptatocytes: A Biocompatible Delivery System for Peptides and Proteins. ACS Applied Nano Materials 2:10, pages 6178-6186.
Crossref
Francesca Biscaglia, Santina Quarta, Gianmarco Villano, Cristian Turato, Alessandra Biasiolo, Lucio Litti, Maria Ruzzene, Moreno Meneghetti, Patrizia Pontisso & Marina Gobbo. (2019) PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting. Materials Science and Engineering: C 103, pages 109762.
Crossref
Kevin A Cannon, Jessica M Ochoa & Todd O Yeates. (2019) High-symmetry protein assemblies: patterns and emerging applications. Current Opinion in Structural Biology 55, pages 77-84.
Crossref
Xingang Guan, Yu Chang, Jinghui Sun, Jianxi Song & Yu Xie. (2018) Engineered Hsp Protein Nanocages for siRNA Delivery. Macromolecular Bioscience 18:5, pages 1800013.
Crossref
Parham Sahandi Zangabad, Mahdi Karimi, Fatemeh Mehdizadeh, Hedieh Malekzad, Alireza Ghasemi, Sajad Bahrami, Hossein Zare, Mohsen Moghoofei, Amin Hekmatmanesh & Michael R. Hamblin. (2017) Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger. Nanoscale 9:4, pages 1356-1392.
Crossref
Eun Jung Lee, Na Kyeong Lee & In-San Kim. (2016) Bioengineered protein-based nanocage for drug delivery. Advanced Drug Delivery Reviews 106, pages 157-171.
Crossref
Yu Zhang, Maziar S. Ardejani & Brendan P. Orner. (2016) Design and Applications of Protein-Cage-Based Nanomaterials. Chemistry - An Asian Journal 11:20, pages 2814-2828.
Crossref
M Rosario Fernández-Fernández, Begoña Sot & José María Valpuesta. (2016) Molecular chaperones: functional mechanisms and nanotechnological applications. Nanotechnology 27:32, pages 324004.
Crossref
Takahiko Tamura, Chiaki Kawabata, Shunsuke Matsushita, Miako Sakaguchi & Shigeto Yoshida. (2016) Malaria sporozoite protein expression enhances baculovirus-mediated gene transfer to hepatocytes. The Journal of Gene Medicine 18:4-6, pages 75-85.
Crossref
Anurag Sankhyan, Chandresh Sharma, Durgashree Dutta, Tarang Sharma, Kunzang Chosdol, Takaji Wakita, Koichi Watashi, Amit Awasthi, Subrat K. Acharya, Navin Khanna, Ashutosh Tiwari & Subrata Sinha. (2016) Inhibition of preS1-hepatocyte interaction by an array of recombinant human antibodies from naturally recovered individuals. Scientific Reports 6:1.
Crossref
Amar BT Ghisaidoobe & Sang J Chung. (2015) Functionalized protein nanocages as a platform of targeted therapy and immunodetection. Nanomedicine 10:24, pages 3579-3595.
Crossref
Masaharu Somiya & Shun'ichi Kuroda. (2015) Development of a virus-mimicking nanocarrier for drug delivery systems: The bio-nanocapsule. Advanced Drug Delivery Reviews 95, pages 77-89.
Crossref
Masaharu Murata, Jing Shu Piao, Sayoko Narahara, Takahito Kawano, Nobuhito Hamano, Jeong-Hun Kang, Daisuke Asai, Ryo Ugawa & Makoto Hashizume. (2015) Expression and characterization of myristoylated preS1-conjugated nanocages for targeted cell delivery. Protein Expression and Purification 110, pages 52-56.
Crossref
Masaharu Murata, Sayoko Narahara, Takahito Kawano, Nobuhito Hamano, Jing Shu Piao, Jeong-Hun Kang, Kenoki Ohuchida, Takashi Murakami & Makoto Hashizume. (2015) Design and Function of Engineered Protein Nanocages as a Drug Delivery System for Targeting Pancreatic Cancer Cells via Neuropilin-1. Molecular Pharmaceutics 12:5, pages 1422-1430.
Crossref
Riki Toita. (2015) Applications of human hepatitis B virus preS domain in bio- and nanotechnology. World Journal of Gastroenterology 21:24, pages 7400.
Crossref
Quan Zhang, Xuanmiao Zhang, Tijia Chen, Xinyi Wang, Yao Fu, Yun Jin, Xun Sun, Tao Gong & Zhirong Zhang. (2015) A safe and efficient hepatocyte-selective carrier system based on myristoylated preS1/21-47 domain of hepatitis B virus. Nanoscale 7:20, pages 9298-9310.
Crossref
Wenjuan Huang, Xia Li, Min Yi, Sufen Zhu & Weixian Chen. (2014) Targeted delivery of siRNA against hepatitis B virus by preS1 peptide molecular ligand. Hepatology Research 44:8, pages 897-906.
Crossref
Jeong-Hun Kang, Riki Toita, Daisuke Asai, Tetsuji Yamaoka & Masaharu Murata. (2014) Liver cell-specific peptides derived from the preS1 domain of human hepatitis B virus. Journal of Virological Methods 201, pages 20-23.
Crossref
Lise Schoonen & Jan C. M. van Hest. (2014) Functionalization of protein-based nanocages for drug delivery applications. Nanoscale 6:13, pages 7124-7141.
Crossref
Riki Toita, Masaharu Murata, Kana Abe, Sayoko Narahara, Jing Shu Piao, Jeong-Hun Kang & Makoto Hashizume. (2013) A nanocarrier based on a genetically engineered protein cage to deliver doxorubicin to human hepatocellular carcinoma cells. Chemical Communications 49:67, pages 7442.
Crossref